Recombinant Human Interferon α2a (Changchun Institute Of Biological Products)

干扰素α-2a生物类似药 (长春生物制品)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Interferon α2a (Changchun Institute Of Biological Products)
Drug Alias Namerecombinant interferon alpha-2a
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A